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TO THE EDITOR
The transplantable B16 melanoma
model has been used for decades and
continues to be used with various de-
grees of reproducibility in mice (Fidler,
1975). Melanocytic tumors or nevus-like
lesions were induced in two-stage
cutaneous chemical oncogenesis experi-
ments in various inbred strains of
mice (Bannasch and Goessner, 1994;
Sundberg et al., 1997; Maronpot et al.,
1999). Recently a number of genetically
engineered mouse models have been
generated to recapitulate the major
signaling pathways deregulated in
human melanoma, namely, the RAS–
RAF–MAPK, PI3K–AKT, CDK4–INK4A–
RB1, and ARF–TP53 pathways (reviewed
in the study by Damsky and Bosenberg
(2010) and Walker et al. (2011)).
These preclinical models have been
invaluable to delineate the relationship
between causative gene mutations
and molecularly targeted therapeutics;
however, there are no spontaneously
occurring melanocytic tumors in labo-
ratory mice to globally discover other
disrupted gene networks. Although
melanomas are relatively common in
humans and domestic animals exposed
to sunlight, the scarcity of spontaneous
melanomas in laboratory mice might be
the result of the mice never being expo-
sed to sunlight or artificial UVR under
normal husbandry conditions. Herein,
we report the finding of a spontaneous,
locally invasive, transplantable malig-
nant melanoma that resembles pigmen-
ted epithelioid melanocytoma (PEM),
formally known as the ‘‘animal/equine-
type’’ in humans (Zembowicz et al.,
2004).
We found a 172-day-old female
LT.B6 ‘‘line E’’ congenic mouse on
routine examination to have multiple
raised black nodules on the tail
(Figure 1a). Histopathology showed dif-
fusely and heavily pigmented dermal
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Figure 1. Clinical and histopathological features of LT.B6 congenic mouse. Multiple black nodules were
noted on the tail of a 172-day-old female mouse (a), scale bar¼7 mm; histologically showing heavily
pigmented dermal nodules (b), scale bar¼200mm; sparing the adnexae (c), scale bar¼ 50mm; surrounding
but not invading the tail nerves (d), scale bar¼ 100mm or the ventral coccygeal artery (e), bar¼50mm.
Accepted article preview online 29 January 2014; published online 6 March 2014
Abbreviations: CT, cycle threshold; LN, lymph node; Mitf, microphthalmia-associated transcription factor;
qRT-PCR, quantitative real-time reverse transcriptase–PCR; PEM, pigmented epithelioid melanocytoma;
Tyrp1, tyrosine-related protein 1
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tumors with irregular borders, and con-
sisting of epithelioid and/or spindled
melanocytes surrounded by numerous
melanophages (Figure 1b and c). These
tumor cells infiltrated fascia between
collagen bundles in the tail, surrounding
nerves, and small arteries, without inva-
sion (Figure 1d and e). We aseptically
removed the nodular masses and finely
minced them in physiological saline
solution and implanted them subcuta-
neously into small incisions between
the scapulae of the dorsal thorax in four
10-week-old histocompatible LT/SvEiJ
female mice. Mice were observed
weekly and the first signs of tumor
growth were observed nearly 12 months
post surgery at the incision site. Of the
four implanted mice, two died of
unrelated reasons, and the remaining
two developed tumors at the injection
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Figure 2. Histopathology and melanocyte-specific gene expression analysis of transplanted melanomas. Subcutaneously transplanted melanomas grew in the
interscapular area of all four mice, giving rise to heavily pigmented dermal nodules (a), scale bar¼ 5 mm, with amelanotic nests and nodules (b), scale
bar¼ 200mm; showing oval nuclei and abundant eosinophilic cytoplasm (c), scale bar¼25mm. After 524 days of transplantation, necropsy showed metastases to
the cervical (d), scale bar¼ 50mm, and popliteal (not shown) lymph nodes (LNs) and lungs (e), scale bar¼25mm. Only melanin (no tumor cells) was found in the
liver sinusoids (f), scale bar¼ 25mm. Quantitative real-time reverse transcriptase–PCR (qRT-PCR) showed specific expression of Tyrp1 and Mitf in the B16
melanoma (positive control) and the LT.B6 tumor but not in chemically-induced squamous cell carcinoma (SCC, negative control) (g). Decreased expression of
Tyrp1 and Mitf was detected in the metastatic LN but not in two liver samples with sinusoidal melanin. Decreased expression of Prkar1a was detected in LT.B6 and
B16 tumors compared with SCC. All reaction assays were performed in triplicate on an ABI 7500 Fast system (Applied Biosystems, Carlsbad, CA) using Sdha as an
endogenous control. The qRT-PCR was repeated showing the same results. Cycle threshold (Ct) values for each mRNA were normalized to Sdha (DCT) and
represented as RQ¼ 2DCT. For comparison, fold differences of all samples were compared with the B16 melanoma.
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site; at necropsy, one mouse had a
2.72.0 1.2 cm3 tumor and the sec-
ond had a 3.4 2.62.0 cm3 tumor.
Complete necropsies (Silva and
Sundberg, 2012) revealed heavily pig-
mented non-ulcerated dermal nodules,
5–15 mm in diameter (Figure 2a).
Overall, the transplanted tumors mor-
phologically resembled the original
donor neoplasms with the exception of
occasional amelanotic whirling nests
consisting of spindle cells with oval
nuclei and abundant eosinophilic cyto-
plasm (Figure 2b and c). There was no
detectable mitotic activity or necrosis in
the primary melanomas. Regional cervi-
cal and popliteal lymph nodes (LNs)
were enlarged, pigmented, and histolo-
gically effaced by metastatic tumors
resembling the primary lesion
(Figure 2d). The nodal metastases were
both subcapsular and intraparenchymal,
similar to the pattern of nodal metas-
tases in melanoma patients (Dadras,
2011). The lungs contained small num-
bers of widely scattered individual
hyperpigmented epithelioid and spind-
led cells in the interalveolar space,
consistent with pulmonary metastases
(Figure 2e). Histopathology of liver sec-
tions showed scattered melanophages
and melanin throughout sinusoids in
the liver parenchyma (Figure 2f). The
images shown here, along with addi-
tional images, are available in color
online on the Mouse Tumor Biology
Database (http://tumor.informatics.jax.
org; Naf et al., 2002; Krupke et al.,
2008). Whole-(virtual) slide images are
available on Skinbase (http://www.
pathbase.net/; Schofield et al., 2010).
To demonstrate melanocyte-specific
gene expression, we subjected
acid-alcohol-fixed, paraffin-embedded
blocks from the transplanted primary
dermal tumors, cervical LN metastasis,
two separate liver blocks, chemically
induced squamous cell carcinoma
(negative control), and B16 transplant
(positive control) to quantitative real-
time reverse transcriptase PCR (qRT-
PCR). Total RNA was extracted from
the blocks as described (Chakraborty
et al., 2013). Using 15 ng total RNA,
the quantification of mouse tyrosine-
related protein 1 (Tyrp1), microph-
thalmia-associated transcription factor
(Mitf), protein kinase, cAMP-dependent
regulatory type 1 alpha (Prkar1a), and
housekeeping gene succinate dehydro-
genase complex subunit A (Sdha) trans-
cripts was accomplished by qRT-PCR
amplification of a cDNA using TaqMan
Universal PCR Master Mix and TaqMan
gene expressions assay probes (Life
Technologies, New York, NY). The fol-
lowing catalog numbers represent the
respective genes analyzed (Life Tech-
nologies): Tyrp1 (Mm00453201_m1),
Mitf (Mm00434954_m1), Prkar1a
(Mm00660315_m1), and Sdha
(Mm01352366_m1). The qRT-PCR
results clearly showed that both Tyrp1
and Mitf are expressed in the LT.B6
mouse primary dermal tumor and B16,
but not in the squamous cell carcinoma
(SCC; Figure 2g). Lower expression
levels of Tyrp1 and Mitf were detected
in the LN metastasis but not in either of
the liver sections, which was consistent
with tumor metastasis to the LN but not
to the liver. The expressions of Tyrp1
and Mitf were only detected in the
melanocytic tumors (B16, primary der-
mal tumor, and LN metastasis) but not in
the SCC or liver sections. The lost
expression of Prkar1a has been reported
as a molecular event in 28 of the PEMs
(82%; Zembowicz et al., 2007). qRT-
PCR for Prkar1a showed 42-fold
decrease in expression in the primary
dermal tumor and LN metastasis, com-
pared with the control (SCC); however,
a similar reduction was also detected in
B16 tumor (Figure 2g).
Historically, the LT strain is light
brown (a, Blt) and was developed from
a mutation at the brown locus in strain
C58 in 1950 and then outcrossed
to BALB/c, and is commonly used
to study spontaneous ovarian teratomas
(Damjanov et al., 1975). The LT.B6
‘‘line E’’ congenic strain was deve-
loped to resolve the genetic interval
containing the ovarian teratoma
susceptibility locus (Ots1; Lee et al.,
1997). Comparing the pathologic fea-
tures of LT.B6 melanomas with human
counterparts showed a remarkable
resemblance to the histopathology of
PEM (Zembowicz et al., 2004): (1)
heavily pigmented dermal tumor
without junctional proliferation or
epidermal hyperplasia, (2) blue nevus-
like architecture, (3) infiltrative borders
with extension into subcutaneous tissue
along peri-adnexal connective tissue of
hair follicles, muscle, or neurovascular
bundles, (4) dendritic and epithelioid
tumor cell cytology, and (5) lack of
tumor necrosis. We detected no mito-
ses in LT.B6 melanomas, whereas low
mitotic activity (1–3 mm2) has been
reported for PEM. The biological
behavior of LT.B6 melanoma is similar
to the clinical behavior of PEM: (1) slow
growth, (2) common metastases to
regional LNs, and (3) rare metastasis to
liver; however, lung metastasis in these
mice is a different feature than PEM. The
finding of a naturally occurring mela-
noma in the laboratory LT.B6 mouse
strain with successful tumor transplan-
tation in two out of two mice followed
by metastases could represent a
clinically relevant mouse model for
melanoma. Therefore, this mouse
neoplasm resembles a variant of human
melanoma of limited metastatic poten-
tial and could provide the opportunity to
globally investigate the genetic and
epigenetic alterations associated with
metastasizing melanoma.
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TO THE EDITOR
Xeroderma pigmentosum (XP) is an
autosomal recessive hereditary disease
that is classified into seven genetic
complementation groups, A through G,
of nucleotide excision repair (NER)-
deficient types and one NER-proficient
variant type (DiGiovanna and Kraemer,
2012). Patients with XP complemen-
tation group D (XPD) display photo-
sensitivity, proneness to skin cancer
and neurological symptoms, but the
severity varies. In XPD from Western
countries, the single amino-acid
change R683W is found in 73% of the
patients and most of them suffer from
neurological symptoms (Takayama
et al., 1995; Kobayashi et al., 1997;
Taylor et al., 1997; Viprakasit et al.,
2001; Kobayashi et al., 2002; Boyle
et al., 2008; Emmert et al., 2009; Ueda
et al., 2009). In contrast, Japanese
patients display only skin manife-
stations without neurological symptoms
(Kobayashi et al., 1997; Taylor et al.,
1997; Kobayashi et al., 2002). XPD
protein is an ATP-dependent 50-30 DNA
helicase, which exerts unwinding of a
damaged DNA strand to facilitate repair
of the DNA. Although the human XPD
protein remains refractory to crystalliza-
tion, the crystal structure of XPD pro-
teins from the archea has been solved
(Fan et al., 2008; Liu et al., 2008). These
structures revealed that XPD functions as
a helicase with two helicase motifs
separated by an ATP-binding cleft and
two additional domains, a Fe–S cluster
and an Arch domain.
In this study, we present six cases of
Japanese XPD without neurological
abnormalities in four families. All
patients showed severe photosensitivity
since birth, and their skin in the sun-
exposed areas was hyperpigmented and
covered with numerous pigmented
maculae with color variations from light
brown to dark brown. Four patients
developed skin cancer, but none of
them show neurological signs. XPD1KO
and XPD4KO were assessed by a
neurologist and an otorhinologist.
Their clinical characteristics have been
summarized in Table 1.
To determine the ability to repair
UV-induced DNA damage, a colony-
formation assay after UV irradiation and
UV-induced unscheduled DNA synth-
esis (UDS) was assessed (Materials and
Methods are described in Supplemen-
tary data). The dose range giving 37%
cell survival and UV-induced UDS in
patients’ cells was much lower com-
pared with that in the healthy subjects
but was higher than that in XP-A cells
(Table 1). Genetic complementation
tests were carried out by means of a
host-cell reactivation assay. Luciferase
activity was increased specifically when
XPD cDNA was cotransfected into each
patient’s cells. Therefore, we concluded
that all cases belonged to XPD. Direct
sequence analysis was performed on
each exon of the genomic DNA ofAccepted article preview online 13 January 2014; published online 13 February 2014
Abbreviations: NER, nucleotide excision repair; UDS, unscheduled DNA synthesis; XP, xeroderma
pigmentosum; XPD, xeroderma pigmentosum complementation group D
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